Log In
Print this Print this

GeneFx Colon signature

  Manage Alerts
Collapse Summary General Information
Company Helomics Corp.
DescriptionDNA microarray-based prognostic assay using formalin-fixed, paraffin-embedded (FFPE) samples
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsPredict recurrence of stage II colon cancer following surgery
Regulatory Designation
PartnerAlmac Group Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today